NRIX - Nurix Therapeutics, Inc.

QQQ $ 610.50 $ -0.16 (-0.03 %)

DIA $ 469.29 $ 2.20 (0.47 %)

SPY $ 671.26 $ -0.01 (0 %)

TLT $ 91.98 $ 0.45 (0.49 %)

GLD $ 379.75 $ -25.91 (-6.43 %)

Previous Close

$ 10.42

Open

$ 10.70

Bid

$ 10.33 x 5

Ask

$ 11.20 x 100

Day's Range

$ 10.15 - $ 10.79

52 Week Range

$ 8.18 - $ 29.56

Volume

709,759

Average Volume

Market Cap

801.13M

Beta (5Y Monthly)

$ 1.37

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-09-2025	08-31-2025	10-Q
2	07-09-2025	05-31-2025	10-Q
3	04-08-2025	02-28-2025	10-Q
4	01-28-2025	11-30-2024	10-K
5	10-11-2024	08-31-2024	10-Q
6	07-11-2024	05-31-2024	10-Q
7	04-10-2024	02-29-2024	10-Q
8	02-15-2024	11-30-2023	10-K
9	10-12-2023	08-31-2023	10-Q
10	07-13-2023	05-31-2023	10-Q
11	04-13-2023	02-28-2023	10-Q
12	02-09-2023	11-30-2022	10-K
13	10-06-2022	08-31-2022	10-Q
14	07-07-2022	05-31-2022	10-Q
15	04-08-2022	02-28-2022	10-Q
16	01-28-2022	11-30-2021	10-K
17	10-14-2021	08-31-2021	10-Q
18	07-13-2021	05-31-2021	10-Q
19	04-13-2021	02-28-2021	10-Q
20	02-16-2021	11-30-2020	10-K
21	10-14-2020	08-31-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Mizuho Initiates Coverage On Nurix Therape...
10/21/2025 12:50:48

Mizuho analyst Joseph Catanzaro initiates coverage on Nurix Therapeutics (NASDAQ:NRIX) with a Outperform rating and announce...

HC Wainwright & Co. Reiterates Buy on Nuri...
10/20/2025 11:51:54

HC Wainwright & Co. analyst Robert Burns reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $33 price ...

Needham Reiterates Buy on Nurix Therapeuti...
10/20/2025 10:15:21

Needham analyst Gil Blum reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $27 price target.

Reported Saturday, Nurix's NX-1607 Achieve...
10/20/2025 08:23:02

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immu...

Morgan Stanley Maintains Equal-Weight on N...
10/14/2025 16:08:43

Morgan Stanley analyst Terence Flynn maintains Nurix Therapeutics (NASDAQ:NRIX) with a Equal-Weight and lowers the price tar...

HC Wainwright & Co. Maintains Buy on Nurix...
10/14/2025 11:22:32

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price targ...

Breaking Down Nurix Therapeutics: 5 Analys...
10/10/2025 13:00:44

Piper Sandler Maintains Overweight on Nuri...
10/10/2025 12:55:59

Piper Sandler analyst Joseph Catanzaro maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and lowers the price tar...

Oppenheimer Maintains Outperform on Nurix ...
10/10/2025 12:26:55

Oppenheimer analyst Matthew Biegler maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and lowers the price target...

nurix-therapeutics-posts-downbeat-q3-results-joins-orthopediatrics-levi-strauss-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Nurix Therapeutics Posts Downbeat Q3 Resul...
10/10/2025 12:02:09

why-applied-digital-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket

Why Applied Digital Shares Are Trading Hig...
10/10/2025 09:06:13

levi-strauss-usana-health-sciences-and-3-stocks-to-watch-heading-into-friday

Levi Strauss, USANA Health Sciences And 3 ...
10/10/2025 06:53:44

US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.

Nurix Therapeutics Q3 EPS $(1.03) Misses $...
10/09/2025 20:03:13

Nurix And Gilead Advance IRAK4 Degrader GS...
09/17/2025 11:10:23

Nurix Therapeutics, Inc. (NASDAQ:NRIX) today announced the presentation of preclinical data from GS-6791/NX-0479, a novel IRAK4...

6 Analysts Assess Nurix Therapeutics: What...
07/31/2025 21:00:25

12 Health Care Stocks Moving In Thursday's...
07/17/2025 21:06:00

Morgan Stanley Maintains Equal-Weight on N...
07/15/2025 12:58:36

Morgan Stanley analyst Terence Flynn maintains Nurix Therapeutics (NASDAQ:NRIX) with a Equal-Weight and lowers the price tar...

A Glimpse Into The Expert Outlook On Nurix...
07/14/2025 21:00:20

HC Wainwright & Co. Maintains Buy on Nurix...
07/14/2025 14:16:28

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price targ...

UBS Maintains Buy on Nurix Therapeutics, L...
07/10/2025 22:10:15

UBS analyst David Dai maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price target from $30 to $26.